galantamine has been researched along with Glaucoma, Suspect in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Almasieh, M; Casanova, C; Di Polo, A; Kelly, ME; MacIntyre, JN; Pouliot, M; Vaucher, E | 1 |
Almasieh, M; Casanova, C; Di Polo, A; Kelly, ME; Zhou, Y | 1 |
2 other study(ies) available for galantamine and Glaucoma, Suspect
Article | Year |
---|---|
Acetylcholinesterase inhibition promotes retinal vasoprotection and increases ocular blood flow in experimental glaucoma.
Topics: Acetylcholinesterase; Animals; Autoradiography; Cell Count; Cell Survival; Cholinesterase Inhibitors; Disease Models, Animal; Fluorescent Antibody Technique, Indirect; Galantamine; Injections, Intraperitoneal; Intraocular Pressure; Male; Ocular Hypertension; Rats; Rats, Inbred BN; Receptors, Muscarinic; Regional Blood Flow; Retinal Ganglion Cells; Retinal Vessels; Vasodilation | 2013 |
Structural and functional neuroprotection in glaucoma: role of galantamine-mediated activation of muscarinic acetylcholine receptors.
Topics: Animals; Axons; Cell Death; Cell Survival; Cytoprotection; Galantamine; Glaucoma; Intraocular Pressure; Neurons; Neuroprotective Agents; Ocular Hypertension; Rats; Rats, Inbred BN; Receptors, Muscarinic; Retinal Ganglion Cells | 2010 |